Financial-condition grades for SEC filers
Company Report · as of Oct 9, 2026
|
| Cibus, Inc.CBUS · chemicals | |
|---|---|
| Grade | Nonecomputable_factors_below_threshold: 6 of 14 inputs computable; 7 are required |
| Reliability | 0.87 AUCfailure model, filers with $120M to $591M assets; 95% interval 0.83 to 0.90; 206 events, 2020 to 2025 |
| Peer failure rate | 1.03% a yearItem 1.03 bankruptcies, same asset band, 2012 to 2025 |
| Size band | $120M to $591M assetstotal assets $305.0M[1] |
| Standard universe | insiderevenue above $1M and assets above $10M[1-2] |
| Warnings | short runway, thin data · fortress balance sheetnot computable: distress |
| Inputs computable | 6 of 14 |
| Graded from | filings received through Mar 17, 2026206 days before the rescan; every figure keyed to the SEC receipt date |
| Last close | $1.592026-10-08; market equity $86.6M; iex feed |
| Price used in grade | None |
| Share price, twelve months to the rescansplit-adjusted close; a lollipop at every rescan carries the letter held then; baseline ticks are SEC receipt dates of the inputs; ranges and dragging scroll the full history | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Percentile at every rescan on file, Jan 21, 2012 to Oct 9, 2026; stronger toward the top. Hover for the date. Open this report as it stood on | ||||||||||||||||||||||||||||
Each date opens the report as it stood on that rescan. |
Business, in the company's words. Opening of Item 1 of the 10-K received Mar 17, 2026; the document on sec.gov.
Cibus is a leading agricultural biotechnology company that primarily uses proprietary gene editing technologies to develop plant traits, which are specific genetic characteristics in the DNA of a plant’s seed. Plant traits, or characteristics, influence how a resulting plant functions and/or interacts with its environment. Cibus produces these edited plant traits by a unique process that is endeavoring to change the scale and speed of plant breeding for many major agricultural crops. Over the course of its history, Cibus has developed a proprietary time bound and predictable gene editing platform referred to as the Rapid Trait Development System™ (RTDS®).
7 checks ran; none of them enters the letter. The checks are listed on the warnings screen.
Lower percentile is stronger. Source numbers open the SEC filing; a range that spans filings opens the sources table.
| Input | Percentile, 0 to 100 | Value | Source | Peer median | Percentile | Peers | Period end |
|---|---|---|---|---|---|---|---|
| Profitability, sleeve percentile 7.3 | |||||||
| Gross profitability | not computable | 21.3% | |||||
| latest aligned inputs end 2022-12-31; latest annual assets end 2025-12-31 | |||||||
| Return on invested capital | not computable | 9.5% | |||||
| pretax income must exceed the validity floor and imply a 0%-100% tax rate | |||||||
| Accruals ratio | (23.4%) | [1,6-8] | (4.2%) | 7.3 | 400 | 2025-12-31 | |
| Gross margin stability, five years | not computable | 2.2 pts | |||||
| five annual gross margins are required; found 4 | |||||||
| Solvency, sleeve percentile 93.1 | |||||||
| Twelve-month failure probability | not computable | 0.05% | |||||
| liabilities and a nearby cover-page share count are required at 2026-06-30 | |||||||
| Altman Z double-prime | (11.34) | [1,9-14] | 3.41 | 90.0 | 301 | 2025-12-31 | |
| Net debt to EBITDA | not computable | 1.88x | |||||
| EBITDA must exceed $100,000 | |||||||
| Interest coverage | not computable | 4.16x | |||||
| interest expense must exceed $100,000 | |||||||
| Current ratio | 0.72x | [9-10] | 2.20x | 96.2 | 423 | 2025-12-31 | |
| Growth and financing, sleeve percentile 30.2 | |||||||
| Revenue growth, three-year compound | 185.1% | [2,15-17] | 1.2% | 0.3 | 350 | 2025-12-31 | |
| Free cash flow growth, three-year compound | not computable | 12.6% | |||||
| current FCF must be positive and base FCF must exceed $100,000 | |||||||
| Reinvestment rate | not computable | 24.3% | |||||
| pretax income must exceed the validity floor and imply a 0%-100% tax rate | |||||||
| Asset growth, three years | 138.7% | [1,8,18-19] | 2.9% | 0.5 | 369 | 2025-12-31 | |
| Net share issuance, one year | 15.6% | [20-21] | 0.0% | 89.7 | 321 | 2023-03-01 | |
Gross profitability. Revenue less cost of goods sold, over total assets.
Accruals ratio. Net income less operating cash flow, over average assets; lower is stronger.
Gross margin stability, five years. Standard deviation of gross margin; lower is stronger.
Twelve-month failure probability. CHS model; lower is stronger.
Net debt to EBITDA. Lower is stronger.
Net share issuance, one year. Split-adjusted; lower is stronger.
Market measures at the 2026-10-08 close. None enters the grade. Percentile among graded peers with the same measure.
| Measure | Value | Peer median | Percentile | Reading |
|---|---|---|---|---|
| Twelve-month price change, skipping the latest month | 25.6% | 13.8% | 61 | hotter than 61 of 100 peers |
| Distance from 52-week high | (60.7%) | (24.2%) | 9 | closer to its high than 9 of 100 peers |
| EBIT to enterprise value | (146.9%) | 3.9% | 0 | pricier than 100 of 100 peers |
| Free cash flow yield | (59.3%) | 3.2% | 2 | pricier than 98 of 100 peers |
| Book value to price | 0.17 | 0.39 | 19 | pricier than 81 of 100 peers |
| Sales to price | 0.04 | 0.57 | 3 | pricier than 97 of 100 peers |
| Composite equity issuance, five years | not computable | (9.9%) | five-year total-return history is required | |
| Relative strength against the sector, log excess return | 0.06 | (0.02) | 58 | ahead of 58 of 100 peers |
Inputs: market equity $86.3M; EBIT -$97.5M; free cash flow -$51.2M; book equity $14.8M; sales $3.6M; debt $528,000; cash $20.4M[22].
Diagnostics do not feed the grade.
| Piotroski F-score: None of 9, period end 2025-12-31 | ||
|---|---|---|
| Return on assets above zero | (36.3%) | ✗ fail[6,8] |
| Operating cash flow above zero | -$50.6M | ✗ fail[7] |
| Return on assets improved | 9.9 pts | ✓ pass[6,8,18,23] |
| Operating cash flow exceeds net income | $76.5M | ✓ pass[6-7] |
| Long-term leverage fell | (0.0 pts) | ✓ pass[1,8,18,24-25] |
| Current ratio improved | (13.7 pts) | ✗ fail[9-10,26-27] |
| No new shares issued | 15.6% | ✗ fail[20-21] |
| Gross margin improved | n/a | |
| Asset turnover improved | 0.3 pts | ✓ pass[2,8,15,18] |
| Cash, filings, liquidity | |
|---|---|
| Cash and equivalents | $20.4M[3] |
| Operating cash flow, four quarters | -$46.1M[3,7,28-31] |
| Months of runway | 5.3 |
| Late filings, two years | 0 |
| NT 10-K or NT 10-Q | |
| Days since last periodic filing | 57 |
| 10-Q received Aug 13, 2026 | |
| Median daily dollar volume | $211,182 |
| 63 sessions | |
| Days since newest grade input | 206 |
|
Every citation on this page. Filing opens the SEC index page for that submission; viewer opens the SEC interactive data for the same filing; series opens the SEC XBRL API record for that tag and company.
| # | Concept | XBRL tag | Value | Period end | Received | Form | Links |
|---|---|---|---|---|---|---|---|
| 1 | assets | us-gaap:Assets | $305.0M | 2025-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 2 | revenue | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | $3.6M | 2025-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 3 | cash | us-gaap:CashAndCashEquivalentsAtCarryingValue | $20.4M | 2026-06-30 | 2026-08-13 | 10-Q | filing · viewer · series |
| 4 | cash | us-gaap:CashAndCashEquivalentsAtCarryingValue | $9.9M | 2025-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 5 | total debt | us-gaap:LongTermDebt | $528,000 | 2025-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 6 | net income | us-gaap:NetIncomeLoss | -$127.1M | 2025-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 7 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$50.6M | 2025-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 8 | assets | us-gaap:Assets | $350.1M | 2024-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 9 | current assets | us-gaap:AssetsCurrent | $12.1M | 2025-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 10 | current liabilities | us-gaap:LiabilitiesCurrent | $16.9M | 2025-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 11 | retained earnings | us-gaap:RetainedEarningsAccumulatedDeficit | -$858.3M | 2025-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 12 | operating income | us-gaap:OperatingIncomeLoss | -$97.5M | 2025-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 13 | book equity | us-gaap:StockholdersEquity | $21.8M | 2025-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 14 | liabilities | us-gaap:Liabilities | $283.2M | 2025-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 15 | revenue | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | $4.3M | 2024-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 16 | revenue | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | $1.8M | 2023-12-31 | 2025-03-20 | 10-K | filing · viewer · series |
| 17 | revenue | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | $157,000 | 2022-12-31 | 2024-03-21 | 10-K | filing · viewer · series |
| 18 | assets | us-gaap:Assets | $544.4M | 2023-12-31 | 2025-03-20 | 10-K | filing · viewer · series |
| 19 | assets | us-gaap:Assets | $22.4M | 2022-12-31 | 2024-03-21 | 10-K | filing · viewer · series |
| 20 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 49,376,160 | 2023-03-01 | 2023-03-03 | 10-K/A | filing · viewer · series |
| 21 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 42,718,930 | 2022-03-03 | 2022-03-03 | 10-K | filing · viewer · series |
| 22 | shares outstanding | us-gaap:CommonStockSharesOutstanding | 54,264,505 | 2025-09-30 | 2025-11-13 | 10-Q | filing · viewer · series |
| 23 | net income | us-gaap:NetIncomeLoss | -$251.4M | 2024-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 24 | long term debt | us-gaap:LongTermDebtNoncurrent | $93,000 | 2025-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 25 | long term debt | us-gaap:LongTermDebtNoncurrent | $226,000 | 2024-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 26 | current assets | us-gaap:AssetsCurrent | $16.9M | 2024-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 27 | current liabilities | us-gaap:LiabilitiesCurrent | $19.9M | 2024-12-31 | 2026-03-17 | 10-K | filing · viewer · series |
| 28 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$20.9M | 2026-06-30 | 2026-08-13 | 10-Q | filing · viewer · series |
| 29 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$11.5M | 2026-03-31 | 2026-05-14 | 10-Q | filing · viewer · series |
| 30 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$37.2M | 2025-09-30 | 2025-11-13 | 10-Q | filing · viewer · series |
| 31 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$25.4M | 2025-06-30 | 2026-08-13 | 10-Q | filing · viewer · series |
Peer group. Sector assignment from four-digit SIC codes, hand-tuned and published. The grade under three alternative peer policies is tabled above.
Size. Within a sector the letter tracks size. Among graded filers in the smallest asset band, 72% grade E and 0% grade A; in the largest, 13% grade E and 21% grade A. Universe as of Oct 9, 2026.
Failure model. filings 2012-01-01 to 2019-12-31 fit, filings 2020-01-01 to 2025-12-31 test; status post hoc pending confirmation. pre-registered on 2026 filings once their 12-month outcome windows close; supported if the paired per-quintile gain over the pooled model has a lower bound above 0.05.
Input validity. Revenue or total assets at or below $100,000 sets the degenerate-inputs flag. An input whose denominator is at or below $100,000 is left not computable rather than ranked.
Returns. No input on this page has a post-2015 confidence interval on returns that excludes zero. The grade ranks reported financial condition and is not a return forecast.
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
